Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TS03 Inc Trust Units TSTIF

Healthcare Medical Instruments & Supplies


GREY:TSTIF - Post by User

TS03 Inc Trust Units > 3 year target. $20
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by counterintuitive247on Jan 08, 2017 11:27pm
188 Views
Post# 25681774

RE:RE:3 year target. $20

RE:RE:3 year target. $20My opinion is that Getinge is waiting for the next level of FDA approvals.  Let TSO3 do all the leg work which will be mid 2018.  Then Getinge needs to clean up their balance sheet. Could be interesting in 2018 as the technology will fully be proven , sterilization market share for TSO3 gained. Could be some other interested parties by then. 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities